Possible scenario
Reimbursement Friction
25% Chance
Payers and Medicare contractors scrutinize the diagnostic, sequencing, and monitoring costs attached to the personalized vaccine workflow. The vaccine still moves forward, but uncertainty over reimbursement slows order conversion and creates near-term volatility for Tempus.
Secondary impacts
- Healthcare -0.1%
Tickers
- TEM-1.9%
- PSNL-1.0%
- MRNA-0.7%
- MRK-0.1%
Portfolio impact
S&P 500-0.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.